ReviewFrontiers in pharmacology2017

Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia.

Habsah Aziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.